» » Work Capacity and Productivity Costs in Early Rheumatoid Arthritis: A Five-year Prospective Study
Download Work Capacity and Productivity Costs in Early Rheumatoid Arthritis: A Five-year Prospective Study djvu

Download Work Capacity and Productivity Costs in Early Rheumatoid Arthritis: A Five-year Prospective Study djvu

by Kari Puolakka

Author: Kari Puolakka
Subcategory: Medicine
Language: English
Publisher: VDM Verlag (August 17, 2009)
Pages: 132 pages
Category: Medicine
Rating: 4.1
Other formats: rtf mobi doc azw

arthritis: A five-year prospective study. Predictors of productivity loss and work disability in early rheumatoid arthritis: A 5-year follow up study. Annals of the Rheumatic Diseases 2005;64:130-133.

Work capacity and productivity costs in early rheumatoid arthritis: A five-year prospective study. Academic dissertation To be presented, with the permission of the Medical Faculty of the University of Helsinki, for public examination in Auditorium XII of the University’s main building on 21 October 2005, at 12:00 noon.

katu 1, FIN-53130 Lappeenranta, Finland.

Department of Medicine, Lappeenranta Central Hospital, Valto Käkelän katu 1, FIN-53130 Lappeenranta, Finland. After 5 years' follow up, data on sick leave and retirement were obtained from social insurance registers or case records. The cumulative duration of sick leaves and RA related disability pensions was counted for each patient. To analyse predictors of productivity loss, the patients were divided into four groups according to duration of work disability per patient year.

In this controlled, prospective 5 year study of patients with recent onset active RA. .Sokka T. Work disability in early rheumatoid arthritis.

In this controlled, prospective 5 year study of patients with recent onset active RA, we show that low education level, older age, and high scores in HAQ and in patient’s and physician’s global assessment of RA severity at baseline predicted longer duration work disability and, consequently, greater losses of productivity. 15 Older people are, on average, less well educated and have fewer chances for successful vocational rehabilitation. In addition, employers may be reluctant to employ older people.

Inflammatory arthritis is associated with a high degree of work instability and financial burden

Inflammatory arthritis is associated with a high degree of work instability and financial burden. In this study, we examine the extent of work instability and financial loss as well as their association with disease characteristics during the first 18 months of inflammatory arthritis. One hundred and four patients in the early phase (more than 6 weeks, < 18 months) of inflammatory arthritis were recruited from a larger early inflammatory arthritis registry.

Rheumatoid arthritis Work capacity impairment Predictors Impact of work disability in early rheumatoid arthritis: a five year randomized.

Rheumatoid arthritis Work capacity impairment Predictors Impact. Arthritis Rheum 50(1):55–62CrossRefGoogle Scholar.

OBJECTIVE Early treatment of patients with rheumatoid arthritis (RA) with . OBJECTIVE To explore the impact of an early treatment response on maintenance of work capacity in patients with early, active rheumatoid arthritis (RA).

OBJECTIVE Early treatment of patients with rheumatoid arthritis (RA) with combination treatment starting with methotrexate, sulfasalazine, hydroxychloroquine and prednisolone (FIN-RACo strategy) i. More). METHODS In the Finnish Rheumatoid Arthriti.

12. rheumatoid arthritis Predictors of productivity loss in early rheumatoid arthritis: a 5-year follow-up study Puolakka et al. rheumatoid arthritis. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources Ruof et al. Ann Rheum Dis 2003. Predictors of productivity loss in early rheumatoid arthritis: a 5-year follow-up study Puolakka et al. Ann Rheum Dis.

Rheumatoid arthritis; Costs; Disability. INTRODUCTION Dr. Bellajdel was supported by a grant from Novartis Pharmaceuticals, Spain. 2 Cost and Correlates of RA in Spain 65 PATIENTS AND METHODS Study population. 1 Cristina Lajas, MD, Lydia Abasolo, MD, Boutayeb Bellajdel, MD, César Hernández-García, MD, PhD, Emilio Vargas, MD, PhD, Juan A. Jover, MD, PhD: Hospital Clínico San Carlos, Madrid, Spain; 2 Loreto Carmona, MD, PhD: Hospital Universitario La Princesa, Madrid, Spain; 3 Pablo Lázaro, MD, PhD: Técnicas Avanzadas de Investigación en Servicios de Salud, Madrid, Spain.

Keywords: Work productivity; Work disability; Absenteeism; Rheumatoid . Puolakka K, Kautiainen H, Möttönen T, Hannonen P, Hakala M, et al. (2005) Predictors of productivity loss in early rheumatoid arthritis: a 5 year follow up study. Annals of the rheumatic diseases 64: 130-133.

Keywords: Work productivity; Work disability; Absenteeism; Rheumatoid arthritis. Rheumatoid arthritis (RA) is a chronic progressive autoimmune disease associated with flares of inflammation and progressive joint erosion, which often lead to a decline in functional status. Escorpizo R, Bombardier C, Boonen A, Hazes JM, Lacaille D, et al.

Conflict of Interest: Dr. Paula Muilu reports a Congress trip from UCB Pharma and a Congress trip from MSD Finland outside the submitted work.

The Finnish Rheumatoid Arthritis Combination-Therapy Trial performed from 1993 to 2000 investigated the efficacy of a combination of three disease-modifying antirheumatic drugs (DMARDs) compared to a single DMARD. Patients with recent-onset active RA were randomized to the two treatment arms for 2 years, after which drug-treatment strategy became unrestricted. At baseline, 162 patients were available for work. After a 5-year follow-up, objective data on sick leave and retirement were gathered from social insurance registers,. The cumulative number of days off work was calculated. The patients who received the combination treatment incurred less RA-related work absence than those who received a single DMARD, on average 78 and 128 work disability days per year, respectively. Early treatment response had a strong impact on maintenance of work capacity. None of the patients in remission at 6 months became permanently work disabled over the 5-year follow-up, whereas 56% of the patients without 20% improvement at 6 months ended on a permanent RA- related disability pension. The monetary value of lost productivity in 5 years was ?2801 and ?74537, respectively.